Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial. (nature.com)

Authors: Kaplan LM … Sanyal AJ Journal: Nature Medicine Published: 2026-06-07 DOI: https://doi.org/10.1038/s41591-026-04479-3